Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Marty

Showing results (151-160 of 526) with videos related to

Pageof 53
Sort By:
Drugs|January 1, 1993
Design and rationale of a randomised comparison of cyclophosphamide, methotrexate and fluorouracil vs fluorouracil, epirubicin and cyclophosphamide in node-positive premenopausal women with operable breast cancer. A trial of the International Collaborative Cancer Group (ICCG)J Wils, R C Coombes, M Marty, et al.
Gastroenterology|January 1, 1980
Antineoplastic agents and the liverD B Ménard, C Gisselbrecht, M Marty, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|October 8, 1981
[Current advances in cancer immunotherapy (author's transl)]D Belpomme, M Marty, C Gisselbrecht, et al.
Lancet (London, England)|August 4, 1984
Treatment of acute non-lymphoblastic leukaemia in elderly patientsJ L Harousseau, S Castaigne, N Milpied, et al.
The European Journal of Prosthodontics and Restorative Dentistry|January 31, 2025
Description and Durability of the Various Direct Restoration Techniques in Molar-Incisor Hypomineralization: A Systematic ReviewR Denis, M Marty, R Esclassan, et al.
Journal of Clinical Microbiology|February 12, 2010
Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosisSophia Koo, Julie M Bryar, Lindsey R Baden, et al.
The New England Journal of Medicine|March 27, 2020
Missing the TargetChristopher Iriarte, Marina Zambrotta, Henrikas Vaitkevicius, et al.
In Vivo (Athens, Greece)|November 25, 1998
Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancerA Ardavanis, J M Extra, M Espié, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 18, 1998
Delayed emesis following anticancer chemotherapyM G Kris, F Roila, P H De Mulder, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1994
Taxoids: a new class of cytotoxic agentsM Marty, J M Extra, S Giacchetti, et al.
Pageof 53

Showing results (151-160 of 526) with videos related to

Sort By:
Pageof 53
Drugs|January 1, 1993
Design and rationale of a randomised comparison of cyclophosphamide, methotrexate and fluorouracil vs fluorouracil, epirubicin and cyclophosphamide in node-positive premenopausal women with operable breast cancer. A trial of the International Collaborative Cancer Group (ICCG)J Wils, R C Coombes, M Marty, et al.
Gastroenterology|January 1, 1980
Antineoplastic agents and the liverD B Ménard, C Gisselbrecht, M Marty, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|October 8, 1981
[Current advances in cancer immunotherapy (author's transl)]D Belpomme, M Marty, C Gisselbrecht, et al.
Lancet (London, England)|August 4, 1984
Treatment of acute non-lymphoblastic leukaemia in elderly patientsJ L Harousseau, S Castaigne, N Milpied, et al.
The European Journal of Prosthodontics and Restorative Dentistry|January 31, 2025
Description and Durability of the Various Direct Restoration Techniques in Molar-Incisor Hypomineralization: A Systematic ReviewR Denis, M Marty, R Esclassan, et al.
Journal of Clinical Microbiology|February 12, 2010
Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosisSophia Koo, Julie M Bryar, Lindsey R Baden, et al.
The New England Journal of Medicine|March 27, 2020
Missing the TargetChristopher Iriarte, Marina Zambrotta, Henrikas Vaitkevicius, et al.
In Vivo (Athens, Greece)|November 25, 1998
Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancerA Ardavanis, J M Extra, M Espié, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 18, 1998
Delayed emesis following anticancer chemotherapyM G Kris, F Roila, P H De Mulder, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1994
Taxoids: a new class of cytotoxic agentsM Marty, J M Extra, S Giacchetti, et al.
Pageof 53